UB Paderborn / Katalog / Suche / in CDI

Regorafenib in the third-line treatment of metastatic colorectal cancer: a retrospective study of 27 cases

Annals of oncology, 2019-07, Vol.30, p.iv41-iv42

2019

Link zum Volltext

Verfügbarkeit prüfen

The management of hepatocellular carcinoma: a report of 19 cases

Annals of oncology, 2019-07, Vol.30, p.iv42-iv42

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of small intestine cancers

Annals of oncology, 2019-07, Vol.30, p.iv9-iv9

2019

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel for the treatment of anal cancer after cisplatin and 5-fluorouracil

Annals of oncology, 2019-07, Vol.30, p.iv1-iv1

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinico epidemiological and therapeutic profile of GIST: Oran center's experience

Annals of oncology, 2018-06, Vol.29, p.v6-v6

2018

Link zum Volltext

Verfügbarkeit prüfen

The management of locally advanced and metastatic colorectal cancer: A retrospective study of 77 cases

Annals of oncology, 2018-06, Vol.29, p.v55-v55

2018

Link zum Volltext

Verfügbarkeit prüfen

P-244 Epidemiology and management of locally advanced and metastatic colorectal cancer RAS wild type: A retrospective study of 70 patients

Annals of oncology, 2023-06, Vol.34, p.S102-S102

2023

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6171-6179

2023

Link zum Volltext

Verfügbarkeit prüfen

RM-042Biliary tract cancer: a retrospective study

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii95-ii95

2016

Link zum Volltext

Verfügbarkeit prüfen

RM-003Neoadjuvant chemotherapy on advanced gastric carcinoma

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii86-ii86

2016

Link zum Volltext

Verfügbarkeit prüfen

RM-023Epidemiology and clinical aspects of the canal anal cancer

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii91-ii91

2016

Link zum Volltext

Verfügbarkeit prüfen

Everolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVERMORE)

Annals of oncology, 2018-10, Vol.29, p.viii316-viii316

2018

Link zum Volltext

Verfügbarkeit prüfen

P-178 Clinico-epidemiological and therapeutic profile of pancreatic cancer: Oran center’s experience

Annals of oncology, 2023-06, Vol.34, p.S79-S79

2023

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria

Cancer treatment and research communications, 2020, Vol.25, p.100220-100220, Article 100220

2020

Link zum Volltext

Verfügbarkeit prüfen

Preoperative concomitant chemoradiotherapy with capecitabine in locally advanced rectal carcinoma

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e15134-e15134

Larbaoui, B.

2009

Link zum Volltext

Verfügbarkeit prüfen

Biomarker testing practices in the SECURE (proSpective obsErvational clinical practiCe stUdy in the first-line management of metastatic colorectal cancer [mCRC] with eRbitux in combination with chemothErapy) study

Annals of oncology, 2017-09, Vol.28, p.v195-v195

2017

Link zum Volltext

Verfügbarkeit prüfen

656P - Middle East & North Africa registry to characterize RAS mutation status and tumour specifications in recently diagnosed patients with metastatic colorectal cancer (MORE-RAS Study)

Annals of oncology, 2019-10, Vol.30, p.v246-v246

2019

Link zum Volltext

Verfügbarkeit prüfen

Middle East & North Africa registry to characterize RAS mutation status and tumour specifications in recently diagnosed patients with metastatic colorectal cancer (MORE-RAS Study)

Annals of oncology, 2019-10, Vol.30, p.v246

2019

Link zum Volltext

Verfügbarkeit prüfen

P-153Regorafenib in the third-line treatment of metastatic colorectal cancer: a retrospective study of 27 cases

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Link zum Volltext

Verfügbarkeit prüfen

P-155The management of hepatocellular carcinoma: a report of 19 cases

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Link zum Volltext

Verfügbarkeit prüfen

RM-023 Epidemiology and clinical aspects of the canal anal cancer

Annals of oncology, 2016-06, Vol.27, p.ii91

2016

Link zum Volltext

Verfügbarkeit prüfen

RM-042 Biliary tract cancer: a retrospective study

Annals of oncology, 2016-06, Vol.27, p.ii95

2016

Link zum Volltext

Verfügbarkeit prüfen

RM-003 Neoadjuvant chemotherapy on advanced gastric carcinoma

Annals of oncology, 2016-06, Vol.27, p.ii86

2016

Link zum Volltext

Verfügbarkeit prüfen

363 (PB-158) - An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting

European journal of cancer (1990), 2018-04, Vol.92, p.S102-S103

2018

Link zum Volltext

Verfügbarkeit prüfen

An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting

European journal of cancer (1990), 2018-04, Vol.92, p.S102-S103

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Regorafenib in the third-line treatment of metastatic colorectal cancer: a retrospective study of 27 cases

The management of hepatocellular carcinoma: a report of 19 cases

Management of small intestine cancers

Paclitaxel for the treatment of anal cancer after cisplatin and 5-fluorouracil

Clinico epidemiological and therapeutic profile of GIST: Oran center's experience

The management of locally advanced and metastatic colorectal cancer: A retrospective study of 77 cases

P-244 Epidemiology and management of locally advanced and metastatic colorectal cancer RAS wild type: A retrospective study of 70 patients

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

RM-042Biliary tract cancer: a retrospective study

RM-003Neoadjuvant chemotherapy on advanced gastric carcinoma

RM-023Epidemiology and clinical aspects of the canal anal cancer

Everolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVERMORE)

P-178 Clinico-epidemiological and therapeutic profile of pancreatic cancer: Oran center’s experience

Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria

Preoperative concomitant chemoradiotherapy with capecitabine in locally advanced rectal carcinoma

Biomarker testing practices in the SECURE (proSpective obsErvational clinical practiCe stUdy in the first-line management of metastatic colorectal cancer [mCRC] with eRbitux in combination with chemothErapy) study

656P - Middle East & North Africa registry to characterize RAS mutation status and tumour specifications in recently diagnosed patients with metastatic colorectal cancer (MORE-RAS Study)

Middle East & North Africa registry to characterize RAS mutation status and tumour specifications in recently diagnosed patients with metastatic colorectal cancer (MORE-RAS Study)

P-153Regorafenib in the third-line treatment of metastatic colorectal cancer: a retrospective study of 27 cases

P-155The management of hepatocellular carcinoma: a report of 19 cases

RM-023 Epidemiology and clinical aspects of the canal anal cancer

RM-042 Biliary tract cancer: a retrospective study

RM-003 Neoadjuvant chemotherapy on advanced gastric carcinoma

363 (PB-158) - An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting

An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting

Suchergebnisse filtern